Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Long-read sequencing quantifies synthetic mRNA abundance, integrity and host response in vivo

Created on 16 Aug 2026

Authors

McLeod, V. M., Yuen, D., Chen, M. Z., Beckham, S. A., Feeney, O. M., Rossi Herling, B., Yang, Y., Molle, L. M., Kaur, P., Payne, T. J., Fabb, S. A., Pouton, C. W., Porter, C. J. H., Johnston, A. P. R.

Abstract

Synthetic mRNA can be used to reprogram biological systems and is increasingly used in vaccines, gene therapies and other advanced therapeutics. However, measuring mRNA abundance, molecular integrity and biological effects in complex samples remains challenging. Existing assays typically quantify short transcript regions or infer delivery from lipid or protein readouts. Here we present a long-read nanopore sequencing method that directly quantifies synthetic mRNA in complex cell and tissue samples. The approach enables absolute quantification of full-length synthetic mRNA, maps degradation at nucleotide resolution and simultaneously profiles associated host transcriptional responses. Applied to lipid nanoparticle (LNP) delivered mRNA in mice, the method revealed tissue-specific delivery and degradation patterns and uncovered a critical disconnect between mRNA accumulation and protein expression across organs. This approach enables integrated measurement of mRNA fate, integrity and biological responses, and will enable mechanistic studies of RNA delivery, stability, translation and innate immune recognition.

Preprint server: bioRxiv
The authors list and abstract were imported from bioRxiv on 16 Aug 2026.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this preprint? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 1
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement